Nehme, Ralda https://orcid.org/0000-0001-7215-3311
Pietiläinen, Olli https://orcid.org/0000-0003-4387-1861
Artomov, Mykyta https://orcid.org/0000-0001-5282-8764
Tegtmeyer, Matthew
Valakh, Vera
Lehtonen, Leevi
Bell, Christina
Singh, Tarjinder https://orcid.org/0000-0003-0601-6815
Trehan, Aditi
Sherwood, John
Manning, Danielle
Peirent, Emily https://orcid.org/0000-0002-3226-7127
Malik, Rhea
Guss, Ellen J. https://orcid.org/0000-0002-2579-8712
Hawes, Derek
Beccard, Amanda
Bara, Anne M.
Hazelbaker, Dane Z.
Zuccaro, Emanuela
Genovese, Giulio https://orcid.org/0000-0003-3066-5575
Loboda, Alexander A.
Neumann, Anna https://orcid.org/0000-0001-7115-8305
Lilliehook, Christina
Kuismin, Outi
Hamalainen, Eija
Kurki, Mitja
Hultman, Christina M.
Kähler, Anna K.
Paulo, Joao A. https://orcid.org/0000-0002-4291-413X
Ganna, Andrea https://orcid.org/0000-0002-8147-240X
Madison, Jon
Cohen, Bruce https://orcid.org/0000-0002-8861-6285
McPhie, Donna
Adolfsson, Rolf
Perlis, Roy
Dolmetsch, Ricardo
Farhi, Samouil https://orcid.org/0000-0003-1359-4568
McCarroll, Steven
Hyman, Steven
Neale, Ben https://orcid.org/0000-0003-1513-6077
Barrett, Lindy E. https://orcid.org/0000-0002-3229-4774
Harper, Wade https://orcid.org/0000-0002-6944-7236
Palotie, Aarno https://orcid.org/0000-0002-2527-5874
Daly, Mark https://orcid.org/0000-0002-0949-8752
Eggan, Kevin https://orcid.org/0000-0003-4436-8467
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (U01MH105669)
Article History
Received: 22 September 2021
Accepted: 8 June 2022
First Online: 27 June 2022
Competing interests
: K.E. is Group Vice President, Head of Research and Early Development at Biomarin Pharmaceuticals and a founder of Q-state Biosciences, Quralis and Enclear. J.W.H. is a founder and advisor of Caraway Therapeutics. The remaining authors declare no competing interests.